Literature DB >> 7598600

Papillary fibroelastoma of the aortic valve presenting with myocardial infarction.

F S Eckstein1, H J Schäfers, J Grote, A Mügge, H G Borst.   

Abstract

We describe the case of a 56-year-old woman who presented with myocardial infarction. Noninvasive and invasive investigations revealed coronary embolism from a papillary tumor attached to the right coronary cusp of the aortic valve as the underlying process. The tumor, which histologically proved to be a papillary fibroelastoma, was excised surgically and the resulting defect in the aortic valve leaflet was closed with a patch of autologous pericardium, effectively reconstructing the aortic valve. The current literature on intracardiac papillary fibroelastoma as a source of embolism and its surgical treatment is summarized.

Entities:  

Mesh:

Year:  1995        PMID: 7598600

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Cardiac valvular papillary fibroelastoma: a report of 2 cases.

Authors:  N Madhu Sankar; M K Odayan; M Morris; H Paterson; W M Hanna
Journal:  Tex Heart Inst J       Date:  1999

2.  Neoplasms involving the heart, their simulators, and adverse consequences of their therapy.

Authors:  W C Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2001-10

3.  Surgical treatment of a cardiac papillary fibroelastoma developing from the chordae of the tricuspid valve: report of a case.

Authors:  Y Nishimura; Y Naito; K Fujiwara; H Komai; Y Noguchi
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

4.  Beating-heart surgical treatment of tricuspid valve papillary fibroelastoma: A case report.

Authors:  Weidong Li; Junnan Zheng; Hengchi Zhao; Hongfei Xu; Yiming Ni
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

5.  Retrospective analysis of 11 cases of primary cardiac valve tumors.

Authors:  Tianbo Li; Chencheng Liu; Yang Luo; Siming Gong; Yingbin Xiao; Xuefeng Wang; Yong Wang
Journal:  Anatol J Cardiol       Date:  2019-01       Impact factor: 1.596

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.